new technologies competing with glp-1 medications 2025 GLP-1R Race in 2025: 8 Essential Takeaways Drug Developers Need to Know GLP-1 Trends: Costs & Coverage

Description

You should be aware that compounded Tirzepatide (GIP and GLP-1 receptor agonist) products are not identical to the approved products Mounjaro and Zepbound

Vaporized cannabis resulted in higher blood THC concentrations than oral cannabis, but the difference did not reach statistical significance ( p 0.05)

Cinnamon as a complementary therapeutic approach for dysglycemia and dyslipidemia control in type 2 diabetes mellitus and its molecular mechanism of action: A review

Multi-functional peptides and Small-molecule oral GLP-RAs In addition to expanding the indications for GLP-1RAs, cutting-edge research on GLP-1RAs is focused more on developing multi-target GLP-1RAs and small-molecule oral GLP-1RAs